SKAN Group AG (SWX:SKAN)
Switzerland · Delayed Price · Currency is CHF 48.40
-1.40 (-2.81%)
Mar 12, 2026, 5:30 PM CET
SKAN Group AG Market Cap
SKAN Group AG has a market cap or net worth of 1.12 billion as of March 12, 2026. Its market cap has decreased by -36.07% in one year.
Market Cap
1.12B
Enterprise Value
1.08B
Revenue
332.13M
Ranking
n/a
PE Ratio
69.22
Stock Price
48.40
Market Cap Chart
Since April 10, 2007, SKAN Group AG's market cap has increased from 47.48M to 1.12B, an increase of 2,257.99%. That is a compound annual growth rate of 18.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 1.12B | -5.68% |
| Dec 30, 2025 | 1.19B | -30.71% |
| Dec 30, 2024 | 1.71B | -5.69% |
| Dec 29, 2023 | 1.82B | 28.25% |
| Dec 30, 2022 | 1.42B | -28.89% |
| Dec 30, 2021 | 1.99B | 1,168.29% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 267.93B |
| Novartis AG | 232.79B |
| Galderma Group AG | 36.26B |
| Lonza Group AG | 34.87B |
| Tecan Group AG | 1.63B |
| Cosmo Pharmaceuticals | 1.60B |
| Aevis Victoria | 1.16B |
| Kuros Biosciences AG | 1.15B |